Evidence map›Paper›PMID 27435497›Full record

ArticleExperimental gerontology2016

Recovery from volumetric muscle loss injury: A comparison between young and aged rats.

John T Kim, Benjamin M Kasukonis, Lemuel A Brown, Tyrone A Washington, Jeffrey C Wolchok

Open access · greenAbstract readComparative Study
In one paragraph

Article in Experimental gerontology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Skeletal Muscle Damage and Inflammation.Advances in experimental medicine and biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Journal of innovative optical health sciences · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

John T KimDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR 72701, United States.
Benjamin M KasukonisDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR 72701, United States.
Lemuel A BrownDepartment of Health, Human Performance, and Recreation, College of Education and Health Professions, University of Arkansas, Fayetteville, AR, Fayetteville, AR 72701, United States.
Tyrone A WashingtonDepartment of Health, Human Performance, and Recreation, College of Education and Health Professions, University of Arkansas, Fayetteville, AR, Fayetteville, AR 72701, United States.
Jeffrey C WolchokDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR 72701, United States. Electronic address: jwolchok@uark.edu.
University of Arkansas at Fayetteville · US

Funding

Engineering a Muscle Mimetic BiomaterialR15AR064481 · NIAMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI WOLCHOK, JEFFREY · 2014 to 2014
$437k
Efficacy testing of an injectable matrix gel for the treatment of fatty muscle infiltrationR15AR073492 · NIAMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI WOLCHOK, JEFFREY · 2018 to 2018
$428k
NIAMS NIH HHS R15 AR064481NIAMS NIH HHS R15 AR073492
6 · The paper itself

Abstract

Termed volumetric muscle loss (VML), the bulk loss of skeletal muscle tissue either through trauma or surgery overwhelms the capacity for repair, leading to the formation of non-contractile scar tissue. The myogenic potential, along with other factors that influence wound repair are known to decline with age. In order to develop effective treatment strategies for VML injuries that are effective across a broad range of patient populations, it is necessary to understand how the response to VML injury is affected by aging. Towards this end, this study was conducted to compare the response of young and aged animal groups to a lower extremity VML injury. Young (3months, n=12) and aged (18months, n=8) male Fischer 344 rats underwent surgical VML injury of the tibialis anterior muscle. Three months after VML injury it was found that young TA muscle was on average 16% heavier than aged muscle when no VML injury was performed and 25% heavier when comparing VML treated young and aged animals (p<0.0001, p<0.0001). Peak contractile force for both the young and aged groups was found to decrease significantly following VML injury, producing 65% and 59% of the contralateral limbs' peak force, respectively (p<0.0001). However, there were no differences found for peak contractile force based on age, suggesting that VML affects muscle's ability to repair, regardless of age. In this study, we used the ratio of collagen I to MyoD expression as a metric for fibrosis vs. myogenesis. Decreasing fiber cross-sectional area with advancing age (p<0.005) coupled with the ratio of collagen I to MyoD expression, which increased with age, supports the thought that regeneration is impaired in the aged population in favor of fibrosis (p=0.0241). This impairment is also exacerbated by the contribution of VML injury, where a 77-fold increase in the ratio of collagen I to MyoD was observed in the aged group (p<0.0002). The aged animal model described in this study provides a tool for investigators exploring not only the development of VML injury strategies but also the effect of aging on muscle regeneration.

Indexed as

Age FactorsMuscle ContractionAnimalsBody WeightCollagen Type IDisease Models, AnimalFibrosisGene ExpressionLinear ModelsMaleMuscle, SkeletalMyoD ProteinOrgan SizeRatsRats, Inbred F344RegenerationCollagen Type IMyoD ProteinAgingAnimal modelMusculoskeletalOrthopedicsTibialis anteriorVML

Identifiers

PMID27435497
PMCPMC5007166
OpenAlexW2482496115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.